Carmichael Hill & Associates, Inc. Abbott Laboratories Transaction History

Carmichael Hill & Associates, Inc.

$279 Million
Q3 2024

A detailed history of Carmichael Hill & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 4,057 shares of ABT stock, worth $475,196. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,057

Previous 4,057 -0.0%

Holding current value

$475,196

Previous $421,000 9.74%

% of portfolio

0.17%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $100 - $112	1 Added 0.02%	4,057 $421,000
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $109 - $120	1 Added 0.02%	4,056 $461,000
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $108,949 - $133,363	-1,208 Reduced 22.95%	4,055 $446,000
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $2,674 - $3,209	-28 Reduced 0.53%	5,263 $509,000
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $80,624 - $89,832	800 Added 17.81%	5,291 $576,000
Q1 2023 Apr 05, 2023	SELL	$96.86 - $114.01 $14,916 - $17,557	-154 Reduced 3.32%	4,491 $454,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $21,388 - $25,092	-225 Reduced 4.62%	4,645 $510,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.02%	4,870 $471,000
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $21,945 - $26,524	215 Added 4.62%	4,869 $529,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $114,134 - $139,179	1,001 Added 27.4%	4,654 $550,000
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $423 - $498	4 Added 0.11%	3,653 $423,000
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $3,885 - $4,233	37 Added 1.02%	3,649 $399,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $5,315 - $6,454	58 Added 1.63%	3,612 $393,000
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $33,307 - $42,630	-435 Reduced 10.9%	3,554 $325,000
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $62 - $91	1 Added 0.03%	3,989 $315,000
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $17,664 - $19,665	225 Added 5.98%	3,988 $346,000
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $11,048 - $11,979	135 Added 3.72%	3,763 $315,000
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $5,101 - $5,950	70 Added 1.97%	3,628 $305,000
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $14,833 - $17,933	-224 Reduced 5.92%	3,558 $284,000
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $2,979 - $3,594	-49 Reduced 1.28%	3,782 $277,000
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $2,878 - $3,177	-50 Reduced 1.29%	3,831 $234,000
Q1 2018 Apr 27, 2018	BUY	$56.27 - $63.62 $56 - $63	1 Added 0.03%	3,881 $233,000
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $208,278 - $222,983	3,880	3,880 $221,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.

Account

Carmichael Hill & Associates, Inc. Abbott Laboratories Transaction History